Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fractyl Laboratories
Biotech
Alto, Fractyl head to public markets with IPOs north of $100M
Alto Neuroscience and Fractyl Health are each set to rake in over $100 million from their respective IPOs this morning.
James Waldron
Feb 2, 2024 8:14am
Fractyl sets out $99M IPO ambitions after busy week for biotechs
Jan 29, 2024 9:31am
Fractyl adds telehealth to Type 2 diabetes device treatment
Aug 1, 2023 12:34pm
Fractyl’s T2D device therapy spurs pancreas function: DDW study
May 23, 2022 9:45am
Fractyl's T2D device shows HbA1c benefits through 2 years
Feb 2, 2022 9:00am
Fractyl nets $100M to finish testing its device therapy for T2D
Jun 16, 2021 9:13am
